199 Publications (Page 7 of 8)
2010
ITF2 is a target of CXCR4 in MDA-MB-231 breast cancer cells and is associated with reduced survival in estrogen receptor-negative breast cancer.
Appaiah, HiteshBhat-Nakshatri, PoornimaMehta, RutikaThorat, Mangesh ABadve, Sunil S and Nakshatri, Harikrishna
Cancer biology & therapy, vol. 10, (no. 6), pp. 600-14, 2010/Sep/15. | Journal Article
 
Prognosis of Hormone-Dependent Breast Cancers: Implications of the Presence of Dysfunctional Transcriptional Networks Activated by Insulin via the Immune Transcription Factor T-bet
McCune, KasiMcCune, KasiBhat-Nakshatri, PoornimaBhat-Nakshatri, PoornimaThorat, Mangesh AThorat, MangeshNephew, KenNephew, KennethBadve, SunilBadve, SunilNakshatri, Harikrishna and Nakshatri, Harikrishna
Cancer Research, vol. 70, (no. 2), pp. 696, 20100115. | Journal Article
 
Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment.
Resetkova, ErikaResetkova, ErikaResetkova, ErikaResetkova, ErikaReis-Filho, JorgeReis Filho, JorgeReis-filho, Jorge SReis-filho, Jorge SJain, Rohit KJain, Rohit KJain, Rohit KJain, RohitMehta, RutikaMehta, RutikaMehta, RutikaMehta, RutikaThorat, Mangesh AThorat, Mangesh AThorat, Mangesh AThorat, MangeshNakshatri, HarikrishnaNakshatri, HarikrishnaNakshatri, HarikrishnaNakshatri, HarikrishnaBadve, SunilBadve, Sunil SBadve, Sunil and Badve, Sunil
Breast cancer research and treatment, vol. 123, (no. 1), pp. 97-108, 2010/Aug. | Journal Article
 
Promise of computational systems biology for cancer clinical trials: the voyage to be realized?
Gökmen-Polar, Yesim and Badve, Sunil
Personalized Medicine, vol. 7, (no. 2), pp. 131, 2010-March-01. | Journal Article
 
SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype.
Bhat-Nakshatri, PoornimaAppaiah, HiteshBallas, Christopher BPick-Franke, PatriciaGoulet, RobertBadve, Sunil SSrour, Edward F and Nakshatri, Harikrishna
BMC cancer, vol. 10, pp. 411, 2010. | Journal Article
 
Subcellular localization of activated AKT in estrogen receptor- and progesterone receptor-expressing breast cancers: potential clinical implications.
Badve, Sunil SCollins, Nikail RBhat-Nakshatri, PoornimaTurbin, DmitryLeung, SamuelThorat, MangeshDunn, Sandra EGeistlinger, Tim RCarroll, Jason SBrown, Myles ABose, ShikhaTeitell, Michael A and Nakshatri, Harikrishna
The American journal of pathology, vol. 176, (no. 5), pp. 2139-49, 2010/May. | Journal Article
2009
Breast Cancer Stem Cells and Intrinsic Subtypes: Controversies Rage On
Nakshatri, HarikrishnaSrour, Edward F and Badve, Sunil S
Current Stem Cell Research and Therapy, vol. 4, (no. 1), pp. 50-60, 2009. | Journal Article
 
Differential gene expression profiling of esophageal adenocarcinoma.
Hammoud, Zane TBadve, Sunil SZhao, QianqianLi, LangSaxena, RomilThorat, Mangesh AMorimiya, AkiraRieger, Karen M and Kesler, Kenneth A
The Journal of thoracic and cardiovascular surgery, vol. 137, (no. 4), pp. 829-34, 2009/Apr. | Journal Article
 
Equivalency of RT-PCR and immunohistochemistry: fact or factoid.
Badve, Sunil S
Breast cancer research and treatment, vol. 116, (no. 1), pp. 145-7, 2009/Jul. | Journal Article
 
FOXA1 in breast cancer.
Nakshatri, Harikrishna and Badve, Sunil
Expert reviews in molecular medicine, vol. 11, pp. e8, 2009. | Journal Article
 
Oestrogen-receptor-positive breast cancer: towards bridging histopathological and molecular classifications.
Badve, Sunil S and Nakshatri, H
Journal of clinical pathology, vol. 62, (no. 1), pp. 6-12, 2009/Jan. | Journal Article
 
Reply to J.M. Guinebretiere and L. Arnould et al
Badve, Sunil SBaehner, Frederick LGray, Robert PChilds, Barrett HMaddala, TaraLiu, Mei-LanRowley, Steve CShak, StevenPerez, Edith AShulman, Lawrence JMartino, SilvanaDavidson, Nancy ESledge, George WGoldstein, Lori J and Sparano, Joseph A
Journal of Clinical Oncology, vol. 27, (no. 16), pp. 2735, 2009-06-01. | Journal Article
2008
Association of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Genetic Polymorphisms With Outcome in a Trial of Paclitaxel Compared With Paclitaxel Plus Bevacizumab in Advanced Breast Cancer: ECOG 2100
Schneider, Bryan PSchneider, BryanWang, MolinWang, MolinRadovich, MilanRadovich, MilanSledge, George WSledge, GeorgeBadve, SunilBadve, SunilThor, AnnThor, AnnFlockhart, DavidFlockhart, David AHancock, BradleyHancock, BradleyDavidson, Nancy EDavidson, NancyGralow, Julie RGralow, JulieDickler, MauraDickler, MauraPerez, Edith APerez, EdithCobleigh, MelodyCobleigh, MelodyShenkier, TamaraShenkier, TamaraEdgerton, SusanEdgerton, SusanMiller, Kathy D and Miller, Kathy
Journal of Clinical Oncology, vol. 26, (no. 28), pp. 4678, 20081001. | Journal Article
 
Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases
Turbin, Dmitry ALeung, SamuelCheang, Maggie CKennecke, Hagen AMontgomery, Kelli DMckinney, StevenTreaba, Diana OBoyd, NikiGoldstein, Lynn CBadve, Sunil SGown, AllenVan De Rijn, JanTorsten, NielsenNielsen, TorstenGilks, Cyril B and Huntsman, David
Breast Cancer Research and Treatment, vol. 110, (no. 3), pp. 417-26, Aug 2008. | Journal Article
 
Consensus recommendations on estrogen receptor testing in breast cancer by immunohistochemistry.
Yaziji, HadiTaylor, Clive RGoldstein, Neal SDabbs, David JHammond, Elizabeth HHewlett, BryanFloyd, Alton DBarry, Todd SMartin, Alvn WBadve, Sunil SBaehner, FrederickCartun, Richard WEisen, Richard NSwanson, Paul EHewitt, Stephen MVyberg, Mogen and Hicks, David G
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry, vol. 16, (no. 6), pp. 513-20, 2008/Dec. | Journal Article
 
Estrogen- and progesterone-receptor status in ECOG 2197: comparison of immunohistochemistry by local and central laboratories and quantitative reverse transcription polymerase chain reaction by central laboratory.
Badve, Sunil SBaehner, RickGray, Robert PChilds, Barrett HMaddala, TaraLiu, Mei-LanRowley, Steve CShak, StevenPerez, Edith AShulman, Lawrence JMartino, SilvanaDavidson, Nancy ESledge, George WGoldstein, Lori J and Sparano, Joseph A
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 26, (no. 15), pp. 2473-81, 2008/May/20. | Journal Article
 
Estrogen promotes tumor progression in a genetically defined mouse model of lung adenocarcinoma.
Hammoud, ZaneTan, BailinBadve, Sunil S and Bigsby, Robert M
Endocrine-related cancer, vol. 15, (no. 2), pp. 475-83, 2008/Jun. | Journal Article
 
Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features.
Goldstein, Lori JGoldstein, Lori JGray, RobertGray, RobertBadve, Sunil SBadve, SunilChilds, Barrett HChilds, Barrett HYoshizawa, CarlYoshizawa, CarlRowley, SteveRowley, SteveShak, StevenShak, StevenBaehner, Frederick LBaehner, RickRavdin, Peter MRavdin, Peter MDavidson, Nancy EDavidson, Nancy ESledge, George WSledge, George WPerez, Edith APerez, Edith AShulman, Lawrence NShulman, Lawrence NMartino, SilvanaMartino, SilvanaSparano, Joseph A and Sparano, Joseph A
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 26, (no. 25), pp. 4063-71, 2008/Sep/1. | Journal Article
 
Prostanoid receptor EP1 expression in breast cancer
Thorat, Mangesh AThorat, Mangesh AMorimiya, AkiraMorimiya, AkiraMehrotra, SanjanaMehrotra, SanjanaKonger, RaymondKonger, RaymondBadve, Sunil S and Badve, Sunil S
Modern Pathology, vol. 21, (no. 1), pp. 15-21, Jan 2008. | Journal Article
2007
A novel biomarker for the detection of esophageal adenocarcinoma.
Hammoud, Zane TBadve, Sunil SSaxena, RomilKesler, Kenneth ARieger, KarenMalkas, Linda H and Hickey, Robert J
The Journal of thoracic and cardiovascular surgery, vol. 133, (no. 1), pp. 82-7, 2007/Jan. | Journal Article
 
A Phase II Study of Single Agent Bortezomib in Patients with Metastatic Breast Cancer: A Single Institution Experience
Engel, Ryan HEngel, Ryan HBrown, Jennifer ABrown, Jennifer AVon Roenn, Jamie HVon Roenn, Jamie HO'Regan, Ruth MO'Regan, Ruth MBergan, RaymondBergan, Raymond CBadve, SunilBadve, SunilRademaker, AlfredRademaker, AlfredGradishar, William J and Gradishar, William J
Cancer Investigation, vol. 25, (no. 8), pp. 737, 20070000. | Journal Article
 
FOXA1 Expression in Breast Cancer-Correlation with Luminal Subtype A and Survival
Badve, Sunil STurbin, DmitryThorat, Mangesh AMorimiya, AkiraTorsten, NielsenPerou, Charles MDunn, SandiHuntsman, David and Nakshatri, Harikrishna
Clinical Cancer Research, vol. 13, (no. 15), pp. 4415-4421, 2007. | Journal Article
 
NF-[kappa]B represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2
Chua, H. LBhat-Nakshatri, P.Clare, S. EMorimiya, A.Badve, Sunil S and Nakshatri, Harikrishna
Oncogene, vol. 26, (no. 5), pp. 711-724, 2007. | Journal Article
 
Predicting response to primary chemotherapy: gene expression profiling of paraffin-embedded core biopsy tissue
Mina, Lida ASoule, Sharon EBadve, Sunil SBaehner, Fredrick LBaker, JoffreCronin, MaureenWatson, DrewMei-Lan, LiuLiu, Mei-LanSledge, George WShak, Steve and Miller, Kathy D
Breast Cancer Research and Treatment, vol. 103, (no. 2), pp. 197-208, Jun 2007. | Journal Article
 
Prognostic factors in invasive breast carcinoma: Do new molecular techniques/profiling add significantly to traditional histological factors?
Thorat, Mangesh A and Badve, Sunil
Current Diagnostic Pathology, vol. 13, (no. 2), pp. 125, 2007. | Journal Article